MindWalk Holdings (HYFT) Net Income towards Common Stockholders (QoQ) (2020 - 2025)
MindWalk Holdings (HYFT) Net Income towards Common Stockholders (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -100.00% |
| Jul 31, 2025 | 91,606.34% |
| Apr 30, 2025 | 195.11% |
| Jan 31, 2025 | -58.29% |
| Oct 31, 2024 | -99.53% |
| Jul 31, 2024 | 661.82% |
| Apr 30, 2024 | -1,725.28% |
| Jan 31, 2024 | -99.87% |
| Oct 31, 2023 | -58.35% |
| Jul 31, 2023 | 9,596.27% |
| Apr 30, 2023 | -4,307.12% |
| Jan 31, 2023 | -80.12% |
| Oct 31, 2022 | 1,191.71% |
| Jul 31, 2022 | 101.98% |
| Apr 30, 2022 | -9,101.06% |
| Jan 31, 2022 | -3,769.52% |
| Oct 31, 2021 | -68.41% |
| Jul 31, 2021 | 99.93% |
| Apr 30, 2021 | -229.34% |
| Jan 31, 2021 | 45.95% |